 |
The Journal of Neuroscience, June 15, 2003, 23(12):5141-5148
Previous Article | Next Article 
Regulation of Natural Cell Death in Dopaminergic Neurons of the Substantia Nigra by Striatal Glial Cell Line-Derived Neurotrophic Factor In Vivo
Tinmarla Frances Oo,1
Nikolai Kholodilov,1 and
Robert E. Burke1,2
Departments of 1Neurology and 2Pathology, The College of Physicians and Surgeons, Columbia University, New York, New York, 10032
Dopamine (DA) neurons of the substantia nigra undergo a developmental cell death event that is biphasic, with peaks just after birth and at postnatal day 14. As envisioned by neurotrophic theory, this cell death is likely to be regulated by target interactions because it is augmented by their disruption. However, the nature of the trophic molecules mediating this regulation are unknown. We showed in vitro that glial cell line-derived neurotrophic factor (GDNF) is able to suppress apoptotic death in DA neurons in postnatal primary culture. We now demonstrate in vivo that administration of GDNF into the striatal target is able to suppress apoptosis. Consistent with a possible physiologic role for endogenous striatal GDNF in regulating this event, two anti-GDNF neutralizing antibodies augment cell death. These antibodies augment cell death only during the first (immediately postnatal) phase of the biphasic death event. We conclude that GDNF is the leading candidate for a target-derived neurotrophic factor for the regulation of the early phase of natural cell death in DA neurons.
Key words: apoptosis; programmed cell death; neurotrophic factors; Parkinson's disease; striatum; substantia nigra
Received Dec. 18, 2002;
revised Mar. 21, 2003;
accepted Mar. 24, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
L.-y. Yu, M. Saarma, and U. Arumae
Death Receptors and Caspases But Not Mitochondria Are Activated in the GDNF- or BDNF-Deprived Dopaminergic Neurons
J. Neurosci.,
July 23, 2008;
28(30):
7467 - 7475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mijatovic, M. Airavaara, A. Planken, P. Auvinen, A. Raasmaja, T. P. Piepponen, F. Costantini, L. Ahtee, and M. Saarma
Constitutive Ret Activity in Knock-In Multiple Endocrine Neoplasia Type B Mice Induces Profound Elevation of Brain Dopamine Concentration via Enhanced Synthesis and Increases the Number of TH-Positive Cells in the Substantia Nigra
J. Neurosci.,
May 2, 2007;
27(18):
4799 - 4809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Ries, C. Henchcliffe, T. Kareva, M. Rzhetskaya, R. Bland, M. J. During, N. Kholodilov, and R. E. Burke
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
PNAS,
December 5, 2006;
103(49):
18757 - 18762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sgado, L. Alberi, D. Gherbassi, S. L. Galasso, G. M. J. Ramakers, K. N. Alavian, M. P. Smidt, R. H. Dyck, and H. H. Simon
Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice
PNAS,
October 10, 2006;
103(41):
15242 - 15247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Salthun-Lassalle, S. Traver, E. C. Hirsch, and P. P. Michel
Substance P, Neurokinins A and B, and Synthetic Tachykinin Peptides Protect Mesencephalic Dopaminergic Neurons in Culture via an Activity-Dependent Mechanism
Mol. Pharmacol.,
November 1, 2005;
68(5):
1214 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. C. Baquet, P. C. Bickford, and K. R. Jones
Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta
J. Neurosci.,
June 29, 2005;
25(26):
6251 - 6259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Salthun-Lassalle, E. C. Hirsch, J. Wolfart, M. Ruberg, and P. P. Michel
Rescue of Mesencephalic Dopaminergic Neurons in Culture by Low-Level Stimulation of Voltage-Gated Sodium Channels
J. Neurosci.,
June 30, 2004;
24(26):
5922 - 5930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kholodilov, O. Yarygina, T. F. Oo, H. Zhang, D. Sulzer, W. Dauer, and R. E. Burke
Regulation of the Development of Mesencephalic Dopaminergic Systems by the Selective Expression of Glial Cell Line-Derived Neurotrophic Factor in Their Targets
J. Neurosci.,
March 24, 2004;
24(12):
3136 - 3146.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|